Share on Facebook Share on Twitter

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
GlaxoSmithKline plant-based COVID vaccine

Ten times the COVID-19 antibodies that infected/recovered people have.  Is the result the same for other vaccines?
The GSX press release had   "about 10 times higher than those in a panel of sera from patients recovering from COVID-19"

Ah... here are the details. on CoVLP+AS03
After 2 doses, at day 42, the neutralizing antibody (NAb) titers were roughly 2000 for both adults and older adults.

I found a comparison of the 9 vaccines approved somewhere in the world.
It reports neutralizing antibody titer for Moderna as 654 and Pfizer as 361.  
It reports the Novavax NVX-CoV2373 NAb titer as 3906
and the Clover SCB-2019 NAb titer as 1810-3320.

I do NOT know that simply having a higher NAb titer is sufficient to indicate it is a better vaccine.  Obviously safety ia major factor.  Also, there is an issue about being effective against variants.

"The vaccine candidate developed by Medicago, a Coronavirus-like particle (CoVLP), is a self-assembling VLP [virus-like particle] that displays trimers of recombinant S protein of SARS-CoV2 embedded into the lipid bilayer of the nanoparticles."

Forum Jump:

Users browsing this thread: